Mean platelet volume is associated with insulin resistance in non-obese, non-diabetic patients with coronary artery disease

Journal of Cardiology

Volumn 56, Issue 2, 2010, Pages 154-158

  Varol, Ercan ^a   Akcay, Selahattin ^a   Ozaydin, Mehmet ^a   Erdogan, Dogan ^a   Dogan, Abdullah ^a   Altinbas, Ahmet ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Coronary artery disease; Insulin resistance; Mean platelet volume

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE INDEX; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; RATING SCALE; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; THROMBOSIS;

BLOOD PLATELETS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 77956012670     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2010.03.005     Document Type: Article

References (37)

1. Reaven G.M. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
2. DeFronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
3. Basili S., Pacini G., Guagnano M.T., Manigrasso M.R., Santilli F., Pettinella C., Ciabattoni G., Patrono C., Davì G. Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 2006, 48:2531-2538.
4. Schneider D.J. Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coron Artery Dis 2005, 16:473-476.
5. Anfossi G., Russo I., Trovati M. Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis 2009, 19:440-449.
6. Park Y., Schoene N., Haris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002, 13:301-306.
7. Tsiara S., Elisaf M., Jagroop I.A., Mikhailidis D.P. Platelets as predictors of vascular risk: is there a practical index of platelet activity?. Clin Appl Thromb Hemost 2003, 9:177-190.
8. Martin J.F. Platelet heterogeneity in vascular disease. Platelet heterogeneity: biology and pathology 1990, 205-226. Springer-Verlag, London. J.F. Martin, E.A. Trowbridge (Eds.).
9. Martin J.F., Trowbridge E.A., Salmon G.L., Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983, 32:443-460.
10. Jakubowski J.A., Thompson C.B., Vaillancourt R., Valeri C.R., Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983, 5:503-511.
11. Giles H., Smith R.E.A., Martin J.F. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994, 24:69-72.
12. Pizzulli L., Yang A., Martin J.F., Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998, 19:80-84.
13. Tavil Y., Sen N., Yazici H.U., Hizal F., Abaci A., Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007, 120:245-250.
14. Coban E., Ozdogan M., Yazicioglu G., Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005, 59:981-982.
15. Hekimsoy Z., Payzin B., Ornek T., Kandogan G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complicat 2004, 18:173-176.
16. Papanas N., Symeonidis G., Maltezos E., Mavridis G., Karavageli E., Vosnakidis T., Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004, 15:475-478.
17. Coban E., Bostan F., Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006, 17:67-69.
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
19. Onat A., Hergenc G., Turkmen S., Yazici M., Sari I., Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 2006, 55:445-452.
20. Muscari A., De Pascalis S., Cenni A., Ludovico C., Castaldini N., Antonelli S., Bianchi G., Magalotti D., Zoli M. Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 2008, 99:1079-1084.
21. Yazici M., Kaya A., Kaya Y., Albayrak S., Cinemre H., Ozhan H. Lifestyle modification decreases the mean platelet volume in prehypertensive patients. Platelets 2009, 20:58-63.
22. Young M.H., Jeng C.Y., Sheu W.H., Shieh S.M., Fuh M.M., Chen Y.D., Reaven G.M. Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease. Am J Cardiol 1993, 72:458-460.
23. Shinozaki K., Suzuki M., Ikebuchi M., Hara Y., Harano Y. Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care 1996, 19:1-7.
24. Bressler P., Bailey S.R., Matsuda M., De Fronzo R.A. Insulin resistance and coronary artery disease. Diabetologia 1996, 39:1345-1350.
25. Rewers M., Zaccaro D., D'Agostino R., Haffner S., Saad M.F., Selby J.V., Bergman R., Savage P. Insulin Resistance Atherosclerosis Study Investigators. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004, 27:781-787.
26. Pyorala M., Miettinen H., Laakso M., Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998, 98:398-404.
27. Despres J.-P., Lamarche B., Mauriege P., Cantin B., Dagenais G.R., Moorjani S., Lupien P.J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952-957.
28. Falcon C., Pfliegler G., Deckmyn H., Vermylen J. The platelet insulin receptor: detection, partial characterization, and search for a function. Biochem Biophys Res Commun 1988, 157:1190-1196.
29. Trovati M., Mularoni E., Burzacca S., Ponziani M.C., Massucco P., Mattiello P., Piretto V., Cavalot F., Anfossi G. Impaired insulin-induced platelet anti-aggregating effect in obesity and in obese non-insulin-dependent diabetes mellitus. Diabetes 1995, 44:1318-1322.
30. Ferreira I.A., Mocking A.I., Feijge M.A., Gorter G., van Haeften T.W., Heemskerk J.W., Akkerman J.W. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2006, 26:417-422.
31. Keating F.K., Sobel B.E., Schneider D.J. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol 2003, 92:1362-1365.
32. Honing M.L., Morrison P.J., Banga J.D., Stroes E.S., Rabelink T.J. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998, 14:241-249.
33. Vizioli L., Muscari S., Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009, 63:1509-1515.
34. Debili N., Masse J.M., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood 1993, 82:84-85.
35. Burstein S.A., Downs T., Friese P., Lynam S., Anderson S., Henthorn J., Epstein R.B., Savage K. Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6. Blood 1992, 80:420-428.
36. Brown A.S., Hong Y., de Belder A., Beacon H., Beeso J., Sherwood R., Edmonds M., Martin J.F., Erusalimsky J.D. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997, 17:802-807.
37. Deveci E., Yesil M., Akinci B., Yesil S., Postaci N., Arikan E., Koseoglu M. Evaluation of insulin resistance in normoglycemic patients with coronary artery disease. Clin Cardiol 2009, 32:32-36.